Table 2 Comparison between treated and control groups (no of patients).

Initial biopsies	No of patients	Repeat biopsies
		Monofocal HGPIN	Plurifocal HGPIN	PCa
Monofocal HGPIN
Treated group	12	1	0	0
Controls	15	3	0	0
Plurifocal HGPIN
Treated group	8	1	0	1
Controls	7	0	3	1
Total no of patients
Treated group	20	2 (10%)	0	1 (5%)
Controls	22	3 (13.6%)	3 (13.6%)	1 (4.5%)

HGPIN, high‐grade prostatic intraepithelial neoplasia; PCa, prostate adenocarcinoma;